Stock QNRX QUOIN PHARMACEUTICALS, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Quoin Pharmaceuticals, Ltd.

Equities

QNRX

US74907L3006

Market Closed - Nasdaq
Other stock markets
 01:30:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
0.5797 USD +0.38% Intraday chart for Quoin Pharmaceuticals, Ltd. -1.76% -88.18%
Jun. 27 Quoin Pharmaceuticals, Ltd. Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome CI
Jun. 06 Certain Options of Quoin Pharmaceuticals, Ltd. are subject to a Lock-Up Agreement Ending on 6-JUN-2024. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome
AQ
Quoin Pharmaceuticals, Ltd. Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome
CI
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference
AQ
Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland
AQ
Certain Options of Quoin Pharmaceuticals, Ltd. are subject to a Lock-Up Agreement Ending on 6-JUN-2024.
CI
Certain Warrants of Quoin Pharmaceuticals, Ltd. are subject to a Lock-Up Agreement Ending on 6-JUN-2024.
CI
Certain American Depositary Shares of Quoin Pharmaceuticals, Ltd. are subject to a Lock-Up Agreement Ending on 6-JUN-2024.
CI
Quoin Pharmaceuticals, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results
AQ
Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024
AQ
Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating
MT
Quoin Pharmaceuticals Seeks M&A Opportunities
CI
Transcript : Quoin Pharmaceuticals, Ltd., Q4 2023 Earnings Call, Mar 14, 2024
Quoin Pharmaceuticals, Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
AQ
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
AQ
ADRs Close Higher; Dada Nexus Ltd. Climbs 30%
DJ
ADRs Slump, Quoin Pharmaceuticals Ltd. Declines 48.3%
DJ
Top Midday Decliners
MT
Quoin Pharmaceuticals Prices $6.5 Million Public Offering; Shares Fall
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QNRX Stock
  4. News Quoin Pharmaceuticals, Ltd.